首页> 外文期刊>AIDS care. >Predictors of early mortality in a cohort of HIV-infected children receiving high active antiretroviral treatment in public hospitals in Ethiopia
【24h】

Predictors of early mortality in a cohort of HIV-infected children receiving high active antiretroviral treatment in public hospitals in Ethiopia

机译:埃塞俄比亚公立医院接受高效抗逆转录病毒治疗的一批感染艾滋病毒的儿童的早期死亡率的预测指标

获取原文
获取原文并翻译 | 示例
           

摘要

Highly active antiretroviral therapy (HAART) is the breakthrough in care and treatment of people living with HIV, leading to a reduction in mortality and an improvement in the quality of life. Without antiretroviral treatment, most HIV-infected children die before their fifth birthday. So the objective of this study is to determine the mortality and associated factors in a cohort of HIV-infected children receiving ART in Ethiopia. A multicentre facility-based retrospective cohort study was done in selected pediatric ART units in hospitals found in Addis Ababa, Ethiopia. The probability of survival was estimated using the Kaplan-Meier method, and multivariate analysis by Cox proportional hazards regression models was conducted to determine the independent predictor of survival. A total of 556 children were included in this study. Of the total children, 10.4% were died in the overall cohort. More deaths (70%) occurred in the first 6 months of ART initiation, and the remaining others were still on follow-up at different hospitals. Underweight (moderate and severe; HR: 10.10; 95% CI: 2.08, 28.00; P = 0.004; and HR: 46.69; 95% CI: 9.26, 200.45; P < 0.01, respectively), advanced disease stage (WHO clinical stages III and IV; HR: 10.13: 95% CI: 2.25, 45.58; P = 0.003), poor ART adherence (HR: 11.72; 95% CI: 1.60, 48.44; P = 0.015), and hemoglobin level less than 7 g/dl (HR: 4.08: 95% CI: 1.33, 12.56; P = 0.014) were confirmed as significant independent predictors of death after controlling for other factors. Underweight, advanced disease stage, poor adherence to ART, and anemia appear to be independent predictor of survival in HIV-infected children receiving HAART at the pediatric units of public hospitals in Ethiopia. Nutritional supplementations, early initiation of HAART, close supervision, and monitoring of patients during the first 6 months, the follow up period is recommended.
机译:高效抗逆转录病毒疗法(HAART)是艾滋病毒感染者护理和治疗领域的突破,可降低死亡率并改善生活质量。没有抗逆转录病毒治疗,大多数感染艾滋病毒的儿童在五岁生日之前死亡。因此,本研究的目的是确定埃塞俄比亚接受抗逆转录病毒治疗的一组艾滋病毒感染儿童的死亡率和相关因素。在埃塞俄比亚亚的斯亚贝巴的医院中,在选定的儿科ART病房中进行了基于多中心设施的回顾性队列研究。使用Kaplan-Meier方法估计生存概率,并通过Cox比例风险回归模型进行多变量分析,以确定生存的独立预测因子。本研究共纳入556名儿童。在整个队列中,有10.4%的儿童死亡。在开始抗病毒治疗的前6个月内,有更多的死亡病例(70%)发生,其余的死亡病例仍在不同医院接受随访。体重不足(中度和重度; HR:10.10; 95%CI:2.08,28.00; P = 0.004; HR:46.69; 95%CI:9.26,200.45; P <0.01),疾病晚期(WHO临床III期) IV; HR:10.13:95%CI:2.25、45.58; P = 0.003),ART依从性差(HR:11.72; 95%CI:1.60、48.44; P = 0.015),血红蛋白水平低于7 g / dl (HR:4.08:95%CI:1.33,12.56; P = 0.014)被确认为控制其他因素后死亡的重要独立预测因子。体重不足,疾病晚期,抗逆转录病毒治疗依从性差和贫血似乎是埃塞俄比亚公立医院儿科接受HAART的HIV感染儿童存活率的独立预测因子。建议在开始的6个月内进行营养补充,尽早开始HAART,密切监督和监测患者。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号